ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Opinion

Coronavirus complicates SoftBank valuation calculations

COVID-19 damages group companies as difficult questions of value and strategy endure

| Japan
Masayoshi Son speaks during a news conference in Tokyo on Feb. 12: the world saw Son throwing money at ventures following nothing but highly fallible gut instinct. (Photo by Yuki Kohara)

Stephen Givens is a corporate lawyer based in Tokyo.

COVID-19 has made it that much harder for investors to figure out SoftBank Group. Pre-coronavirus, it was already plenty complex.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more